Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, Tan KS, Wang DY, Yan Y (2020) The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res 13;7(1):11. https://doi.org/10.1186/s40779-020-00240-0

Article  Google Scholar 

Wang C, Horby PW, Hayden FG, Gao GF (2020) A novel coronavirus outbreak of global health concern. Lancet 15;395(10223):470–473. https://doi.org/10.1016/s0140-6736(20)30185-9

Article  Google Scholar 

Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, Hu Y, Tao ZW, Tian JH, Pei YY et al (2020) A new coronavirus associated with human respiratory disease in China. Nature 579(7798):265–269. https://doi.org/10.1038/s41586-020-2008-3

Article  Google Scholar 

Hu B, Guo H, Zhou P, Shi ZL (2021) Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol 319:141–154. https://doi.org/10.1038/s41579-020-00459-7

Article  Google Scholar 

Wang MY, Zhao R, Gao LJ, Gao XF, Wang DP, Cao JM (2020) SARS-CoV-2: structure, Biology, and structure-based therapeutics Development. Front Cell Infect Microbiol 25:10:587269. https://doi.org/10.3389/fcimb.2020.587269

Article  PubMed  PubMed Central  Google Scholar 

Edara VV, Lai L, Sahoo MK, Floyd K, Sibai M, Solis D, Flowers MW, Hussaini L, Ciric CR, Bechnack S et al (2021) Infection and vaccine-induced neutralizing antibody responses to the SARS-CoV-2 B.1.617.1 variant. https://doi.org/10.1101/2021.05.09.443299. bioRxiv

Hoffmann M, Krüger N, Schulz S, Cossmann A, Rocha C, Kempf A, Nehlmeier I, Graichen L, Moldenhauer AS, Winkler MS et al (2022) The Omicron variant is highly resistant against antibody-mediated neutralization: implications for control of the COVID-19 pandemic. Cell 3185:447–456. https://doi.org/10.1016/j.cell.2021.12.032

Article  Google Scholar 

McCallum M, Czudnochowski N, Rosen LE, Zepeda SK, Bowen JE, Walls AC, Hauser K, Joshi A, Stewart C, Dillen JR et al (2022) Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement. Science 6583375:864–868. https://doi.org/10.1126/science.abn8652

Article  Google Scholar 

Dhama K, Nainu F, Frediansyah A, Yatoo MI, Mohapatra RK, Chakraborty S, Zhou H, Islam MR, Mamada SS, Kusuma HI et al (2023) Global emerging Omicron variant of SARS-CoV-2: impacts, challenges and strategies. J Infect Public Health 116:4–14. https://doi.org/10.1016/j.jiph.2022.11.024

Article  Google Scholar 

Dai L, Zheng T, Xu K, Han Y, Xu L, Huang E, An Y, Cheng Y, Li S, Liu M et al (2020) A Universal Design of Betacoronavirus vaccines against COVID-19, MERS, and SARS. Cell 3182:722–73. https://doi.org/10.1016/j.cell.2020.06.035

Article  Google Scholar 

Evans JP, Zeng C, Carlin C, Lozanski G, Saif LJ, Oltz EM, Gumina RJ, Liu SL (2022) Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough infection. Sci Transl Med 63714:eabn8057. https://doi.org/10.1126/scitranslmed.abn8057

Article  Google Scholar 

Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL et al (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 7798579:270–273. https://doi.org/10.1038/s41586-020-2012-7

Article  Google Scholar 

Kirtipal N, Bharadwaj S, Kang SG (2020) From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses. Infect Genet Evol 85:104502. https://doi.org/10.1016/j.meegid.2020.104502

Article  PubMed  PubMed Central  Google Scholar 

Llanes A, Restrepo CM, Caballero Z, Rajeev S, Kennedy MA, Lleonart R (2020) Betacoronavirus genomes: how genomic information has been used to deal with past outbreaks and the COVID-19 pandemic. Int J Mol Sci 26;21(12):4546. https://doi.org/10.3390/ijms21124546

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N et al (2020) Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 22;395(10224):565–574. https://doi.org/10.1016/s0140-6736(20)30251-8

Article  Google Scholar 

Xiao K, Zhai J, Feng Y, Zhou N, Zhang X, Zou JJ, Li N, Guo Y, Li X, Shen X et al (2020) Isolation of SARS-CoV-2-related coronavirus from Malayan pangolins. Nature 7815583:286–289. https://doi.org/10.1038/s41586-020-2313-x

Article  Google Scholar 

Zhang S, Qiao S, Yu J, Zeng J, Shan S, Tian L, Lan J, Zhang L, Wang X (2021) Bat and pangolin coronavirus spike glycoprotein structures provide insights into SARS-CoV-2 evolution. Nat Commun 11;12(1):1607. https://doi.org/10.1038/s41467-021-21767-3

Article  Google Scholar 

Hills FR, Eruera AR, Hodgkinson-Bean J, Jorge F, Easingwood R, Brown SHJ, Bouwer JC, Li YP, Burga LN, Bostina M (2024) Variation in structural motifs within SARS-related coronavirus spike proteins. PLoS Pathog 28;20(5):e1012158. https://doi.org/10.1371/journal.ppat.1012158

Article  Google Scholar 

Wu L, Chen Q, Liu K, Wang J, Han P, Zhang Y, Hu Y, Meng Y, Pan X, Qiao C et al (2020) Broad host range of SARS-CoV-2 and the molecular basis for SARS-CoV-2 binding to cat ACE2. Cell Discov 29:6:68. https://doi.org/10.1038/s41421-020-00210-9

Article  PubMed  PubMed Central  Google Scholar 

Fang E, Liu X, Li M, Zhang Z, Song L, Zhu B, Wu X, Liu J, Zhao D, Li Y (2022) Advances in COVID-19 mRNA vaccine development. Signal Transduct Target Ther 23;7(1):94. https://doi.org/10.1038/s41392-022-00950-y

Article  Google Scholar 

Zhou Y, Zhi H, Teng Y (2023) The outbreak of SARS-CoV-2 omicron lineages, immune escape, and vaccine effectivity. J Med Virol 195:e28138. https://doi.org/10.1002/jmv.28138

Article  Google Scholar 

Mlcochova P, Kemp SA, Dhar MS, Papa G, Meng B, Ferreira I, Datir R, Collier DA, Albecka A, Singh S et al (2021) SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion. Nature 7883599:114–119. https://doi.org/10.1038/s41586-021-03944-y

Article  Google Scholar 

Shiehzadegan S, Alaghemand N, Fox M, Venketaraman V (2021) Analysis of the Delta variant B.1.617.2 COVID-19. Clin Pract 411:778–784. https://doi.org/10.3390/clinpract11040093

Article  Google Scholar 

Tian D, Sun Y, Xu H, Ye Q (2022) The emergence and epidemic characteristics of the highly mutated SARS-CoV-2 Omicron variant. J Med Virol 694:2376–2383. https://doi.org/10.1002/jmv.27643

Article  Google Scholar 

Iketani S, Liu L, Guo Y, Liu L, Chan JF, Huang Y, Wang M, Luo Y, Yu J, Chu H et al (2022) Antibody evasion properties of SARS-CoV-2 Omicron sublineages. Nature 604(7906):553–556. https://doi.org/10.1038/s41586-022-04594-4

Article  Google Scholar 

Ahmad ZA, Yeap SK, Ali AM, Ho WY, Alitheen NB, Hamid M (2012) scFv antibody: principles and clinical application. Clin Dev Immunol 2012:980250. https://doi.org/10.1155/2012/980250

Schubert M, Bertoglio F, Steinke S, Heine PA, Ynga-Durand MA, Maass H, Sammartino JC, Cassaniti I, Zuo F, Du L et al (2022) Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant. BMC Med 3;20(1):102. https://doi.org/10.1186/s12916-022-02312-5

Article  Google Scholar 

Ren SY, Wang WB, Gao RD, Zhou AM (2022) Omicron variant (B.1.1.529) of SARS-CoV-2: mutation, infectivity, transmission, and vaccine resistance. World J Clin Cases 7;10(1):1–11. https://doi.org/10.12998/wjcc.v10.i1.1

Article  Google Scholar 

Gruell H, Vanshylla K, Weber T, Barnes CO, Kreer C, Klein F (2022) Antibody-mediated neutralization of SARS-CoV-2. Immunity 655:925–944. https://doi.org/10.1016/j.immuni.2022.05.005

Article  Google Scholar 

Wu C, Ying H, Grinnell C, Bryant S, Miller R, Clabbers A, Bose S, McCarthy D, Zhu RR, Santora L et al (2007) Simultaneous targeting of multiple disease mediators by a dual-variable-domain immunoglobulin. Nat Biotechnol 1125:1290–1297. https://doi.org/10.1038/nbt1345

Article  Google Scholar 

Acheampong DO (2019) Bispecific antibody (bsAb) construct formats and their application in Cancer Therapy. Protein Pept Lett 726:479–493. https://doi.org/10.2174/0929866526666190311163820

Article  Google Scholar 

Nyakatura EK, Soare AY, Lai JR (2017) Bispecific antibodies for viral immunotherapy. Hum Vaccin Immunother 413:836–842. https://doi.org/10.1080/21645515.2016.1251536

Article  Google Scholar 

Wu L, Gao Y, Yu D, Liu S, Zhao R, Liu D, Xu L, Liu H, Wang X, Qi J et al (2023) VH-CH1 switch region-inserting multispecific antibody designs and their efficacy against SARS-CoV-2 in vitro and in vivo. Cell Discov 19:113. https://doi.org/10.1038/s41421-023-00616-1

Article  Google Scholar 

Wang Y, Zhang X, Ma Y, Wang Y, Zhan W, Zheng Q, Zhang M, Ji P, Liu M, Liu Q et al (2022) Combating the SARS-CoV-2 Omicron (BA.1) and BA.2 with potent bispecific antibodies engineered from non-omicron neutralizing antibodies. Cell Discov 18:104. https://doi.org/10.1038/s41421-022-00463-6

Article  Google Scholar 

Ku Z, Xie X, Lin J, Gao P, Wu B, El Sahili A, Su H, Liu Y, Ye X, Tan EY et al (2022) Engineering SARS-CoV-2 specific cocktail antibodies into a bispecific format improves neutralizing potency and breadth. Nat Commun 22;13(1):5552. https://doi.org/10.1038/s41467-022-33284-y

Article  Google Scholar 

de Assis LH, Fassi DE, Hutchings M (2023) Bispecific antibody therapies. Hematol Am Soc Hematol Educ Program 12023:216–222. https://doi.org/10.1182/hematology.2023000508

Article  Google Scholar 

Chen J, Yang J, Chang F, Hu Y, Wu Q, Teng S, Liu Y, Zhang J, He R, Liu B et al (2023) Identification of broad neutralizing antibodies against Omicron subvariants from COVID-19 convalescents and vaccine recipients. Virol Sin 238:313–316. https://doi.org/10.1016/j.virs.2023.01.005

Article  Google Scholar 

Y. Hu, Q. Wu, F. Chang, J. Yang, X. Zhang, Q. Wang, J. Chen, S. Teng, Y. Liu, et al. (2024) Broad cross-neutralizing antibodies against animal-associated sarbecoviruses generated by SARS-CoV-2 infection and vaccination in humans. NPJ Vaccines Oct 22;9(1):195. Http: //doi.org/10.1038/s41541-024-00997-8.